PeptiDream Inc. (4587.T)
JPY 2603.5
(-0.53%)
JPY 2603.5
(-0.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.4 Billion JPY | -10.25% |
| 2022 | 2.67 Billion JPY | 189.55% |
| 2021 | 925.13 Million JPY | 57.88% |
| 2020 | 585.98 Million JPY | 71.68% |
| 2019 | 341.31 Million JPY | 18.62% |
| 2018 | 287.74 Million JPY | 73.17% |
| 2017 | 166.16 Million JPY | -20.86% |
| 2016 | 209.97 Million JPY | 20997899900.0% |
| 2015 | 1.00 JPY | -100.0% |
| 2014 | 81.33 Million JPY | 195.3% |
| 2013 | 27.54 Million JPY | -33.34% |
| 2012 | 41.32 Million JPY | 0.0% |
| 2011 | - JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.78 Billion JPY | 1.88% |
| 2024 Q1 | 2.73 Billion JPY | 13.9% |
| 2023 Q2 | 2.64 Billion JPY | -1.9% |
| 2023 Q3 | 2.77 Billion JPY | 4.77% |
| 2023 FY | 2.4 Billion JPY | -10.25% |
| 2023 Q4 | 2.4 Billion JPY | -13.25% |
| 2023 Q1 | 2.69 Billion JPY | 0.66% |
| 2022 Q4 | 2.67 Billion JPY | 12.24% |
| 2022 FY | 2.67 Billion JPY | 189.55% |
| 2022 Q3 | 2.38 Billion JPY | 6.91% |
| 2022 Q2 | 2.23 Billion JPY | 7.51% |
| 2022 Q1 | 2.07 Billion JPY | 124.44% |
| 2021 Q1 | 655.33 Million JPY | 11.84% |
| 2021 Q4 | 925.13 Million JPY | 10.49% |
| 2021 Q3 | 837.32 Million JPY | 10.56% |
| 2021 FY | 925.13 Million JPY | 57.88% |
| 2021 Q2 | 757.36 Million JPY | 15.57% |
| 2020 Q3 | 444.4 Million JPY | 10.11% |
| 2020 Q4 | 585.98 Million JPY | 31.86% |
| 2020 FY | 585.98 Million JPY | 71.68% |
| 2020 Q2 | 403.59 Million JPY | 11.72% |
| 2020 Q1 | 361.24 Million JPY | 0.0% |
| 2019 FY | 341.31 Million JPY | 18.62% |
| 2019 Q3 | 337.34 Million JPY | 17.24% |
| 2019 Q2 | 287.74 Million JPY | 3.92% |
| 2019 Q1 | 276.9 Million JPY | 22.46% |
| 2018 FY | 287.74 Million JPY | 73.17% |
| 2018 Q4 | 226.12 Million JPY | 16.16% |
| 2018 Q3 | 194.67 Million JPY | 17.15% |
| 2018 Q2 | 166.16 Million JPY | 0.0% |
| 2018 Q1 | - JPY | 0.0% |
| 2017 Q3 | 567.56 Million JPY | 170.3% |
| 2017 Q1 | - JPY | 0.0% |
| 2017 FY | 166.16 Million JPY | -20.86% |
| 2017 Q2 | 209.97 Million JPY | 0.0% |
| 2017 Q4 | - JPY | -100.0% |
| 2016 Q3 | - JPY | -100.0% |
| 2016 FY | 209.97 Million JPY | 20997899900.0% |
| 2016 Q1 | - JPY | 0.0% |
| 2016 Q2 | 1.00 JPY | 0.0% |
| 2016 Q4 | - JPY | 0.0% |
| 2015 Q2 | 81.33 Million JPY | 485.0% |
| 2015 FY | 1.00 JPY | -100.0% |
| 2015 Q4 | - JPY | -100.0% |
| 2015 Q3 | 26.11 Million JPY | -67.9% |
| 2015 Q1 | 13.9 Million JPY | 12.02% |
| 2014 Q3 | 1.00 JPY | -100.0% |
| 2014 FY | 81.33 Million JPY | 195.3% |
| 2014 Q1 | - JPY | 0.0% |
| 2014 Q4 | 12.41 Million JPY | 1241199900.0% |
| 2014 Q2 | 27.54 Million JPY | 0.0% |
| 2013 Q4 | - JPY | 0.0% |
| 2013 Q3 | - JPY | 0.0% |
| 2013 Q2 | - JPY | 0.0% |
| 2013 FY | 27.54 Million JPY | -33.34% |
| 2012 FY | 41.32 Million JPY | 0.0% |
| 2011 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -251.994% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -13309.315% |
| GNI Group Ltd. | 2.33 Billion JPY | -3.155% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | -7.921% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -3462.715% |
| Soiken Holdings Inc. | 1.12 Billion JPY | -114.49% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -2222.093% |
| AnGes, Inc. | 1.61 Billion JPY | -48.79% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -3148.903% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 17.184% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -646.834% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -1306506.522% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -1615.539% |
| CanBas Co., Ltd. | 728 Thousand JPY | -330141.209% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -2636.255% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -1525.1% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -3650.224% |
| Kidswell Bio Corporation | 875.65 Million JPY | -174.555% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -44904.792% |
| Ribomic Inc. | 2.27 Million JPY | -105623.659% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -240415599900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -6578.211% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -8190.193% |
| CellSource Co., Ltd. | 305.92 Million JPY | -685.865% |
| FunPep Company Limited | 25.54 Million JPY | -9312.928% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -560.381% |
| Stella Pharma Corporation | 1.11 Billion JPY | -115.377% |
| TMS Co., Ltd. | 50.02 Million JPY | -4705.909% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -11402.588% |
| Cuorips Inc. | 1.04 Million JPY | -230403.931% |
| K Pharma,Inc. | 10.79 Million JPY | -22173.078% |
| Takara Bio Inc. | 11.85 Billion JPY | 79.712% |
| ReproCELL Incorporated | 248.14 Million JPY | -868.871% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -433.561% |
| StemCell Institute Inc. | 42.26 Million JPY | -5588.694% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -951.848% |
| CellSeed Inc. | 46.19 Million JPY | -5104.815% |